FV

Fonds Vives II (University of Louvain, UCL)

Description

Fonds Vives II (University of Louvain, UCL)

Investor Profile

Fonds Vives II (University of Louvain, UCL) has made 5 investments, with 0 in the past 12 months and 0% as lead.

Stage Focus

  • Series B (40%)
  • Series A (40%)
  • Seed (20%)

Country Focus

  • Belgium (60%)
  • United States (40%)

Industry Focus

  • Biotechnology
  • Health Care
  • Medical
  • Health Diagnostics
  • Home Health Care
  • Lifestyle
  • Medical Device
  • Wellness
  • Biopharma
  • Life Science
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Fonds Vives II (University of Louvain, UCL) frequently co-invest with?

HBM Partners
Europe, Zug, Switzerland, Zug
Co-Investments: 1
Seventure Partners
Europe, Ile-de-France, France, Paris
Co-Investments: 2
MPM Capital
North America, Massachusetts, United States, Boston
Co-Investments: 1
Fund+
Europe, Vlaams-Brabant, Belgium, Leuven
Co-Investments: 2
Kurma Partners
Europe, Ile-de-France, France, Paris
Co-Investments: 1
European Innovation Council
Europe, Brussels Hoofdstedelijk Gewest, Belgium, Brussels
Co-Investments: 1
6 Dimensions Capital
Asia, Shanghai, China, Shanghai
Co-Investments: 1
S.R.I.W.
Europe, Liege, Belgium, Liège
Co-Investments: 2
SFPI-FPIM
Europe, Brussels Hoofdstedelijk Gewest, Belgium, Brussels
Co-Investments: 2
CV
North America, Texas, United States, Dallas
Co-Investments: 1

Which angels does Fonds Vives II (University of Louvain, UCL) often collaborate with?

PD
Europe, Brussels Hoofdstedelijk Gewest, Belgium, Brussels
Shared Deals: 1

What are some of recent deals done by Fonds Vives II (University of Louvain, UCL)?

Sunrise

Brussels, Brussels Hoofdstedelijk Gewest, Belgium

We are a virtual sleep clinic, using our own 3-gram sensor to diagnose sleep with gold standard quality.

Health CareHealth DiagnosticsHome Health CareLifestyleMedical DeviceWellness
SeedDec 15, 2021
Amount Raised: $7,338,604
Virovet

Leuven, Vlaams-Brabant, Belgium

ViroVet is a pioneering company.

BiotechnologyPharmaceuticalVeterinary
Series BMay 28, 2020
Amount Raised: $6,647,249
ITeos Therapeutics

Cambridge, Massachusetts, United States

ITeos Therapeutics is a biotechnology company that specializes in tumor immunology, cancer immunotherapy, and drug discovery.

BiotechnologyHealth CareMedical
Series BJun 20, 2018
Amount Raised: $75,000,000
A-Mansia Biotech

Louvain-la-neuve, Vlaams-Brabant, Belgium

A-Mansia Biotech is a developer of products based on the properties of the Akkermansia muciniphila (A. muciniphila) bacterium.

BiopharmaBiotechnologyLife Science
Series AApr 27, 2018
Amount Raised: $15,790,497
ITeos Therapeutics

Cambridge, Massachusetts, United States

ITeos Therapeutics is a biotechnology company that specializes in tumor immunology, cancer immunotherapy, and drug discovery.

BiotechnologyHealth CareMedical
Series AMay 3, 2012
Amount Raised: $11,830,415